Raymond James Financial
GMAB icon

Raymond James Financial’s Genmab GMAB Stock Holding History

Raymond James Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
69,579
+2,677
+4% +$71.1K ﹤0.01% 3515
2026
Q1 		$1.78M Buy
66,902
+19,046
+40% +$571K ﹤0.01% 3444
2025
Q4 		$1.49M Buy
47,856
+12,288
+35% +$383K ﹤0.01% 3509
2025
Q3 		$1.09M Buy
35,568
+4,422
+14% +$108K ﹤0.01% 3623
2025
Q2 		$643K Buy
31,146
+10,113
+48% +$208K ﹤0.01% 3847
2025
Q1 		$412K Sell
21,033
-96,969
-82% -$2.03M ﹤0.01% 4048
2024
Q4 		$2.46M Buy
+118,002
New +$2.59M ﹤0.01% 2819

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Raymond James Financial's GMAB Position: Q2 2026 in Review

Raymond James Financial increased its Genmab (GMAB) stake by 4% in Q2 2026, buying an estimated $71.1K and bringing the position to 69,579 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3515.

Raymond James Financial first reported a position in GMAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.46M in Q4 2024. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Raymond James Financial held 69,579 shares of Genmab worth $1.91M as of Q2 2026.
  • Raymond James Financial bought 2,677 Genmab shares in Q2 2026, an estimated $71.1K.
  • Genmab made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3515 holding.
  • Raymond James Financial first reported a position in Genmab in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Genmab position peaked at $2.46M in Q4 2024.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.